Alliancebernstein L.P. trimmed its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 37.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 452,584 shares of the real estate investment trust's stock after selling 276,415 shares during the period. Alliancebernstein L.P. owned approximately 0.16% of Omega Healthcare Investors worth $17,234,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the stock. AQR Capital Management LLC lifted its holdings in Omega Healthcare Investors by 430.8% in the first quarter. AQR Capital Management LLC now owns 2,862,117 shares of the real estate investment trust's stock valued at $108,989,000 after buying an additional 2,322,878 shares during the period. Advisors Asset Management Inc. lifted its holdings in Omega Healthcare Investors by 22.1% in the first quarter. Advisors Asset Management Inc. now owns 148,896 shares of the real estate investment trust's stock valued at $5,670,000 after buying an additional 26,978 shares during the period. Focus Partners Advisor Solutions LLC acquired a new position in Omega Healthcare Investors in the first quarter valued at approximately $379,000. Royal Bank of Canada lifted its holdings in Omega Healthcare Investors by 29.4% in the first quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust's stock valued at $5,496,000 after buying an additional 32,798 shares during the period. Finally, Landscape Capital Management L.L.C. lifted its holdings in Omega Healthcare Investors by 78.0% in the first quarter. Landscape Capital Management L.L.C. now owns 52,141 shares of the real estate investment trust's stock valued at $1,986,000 after buying an additional 22,847 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.
Omega Healthcare Investors Trading Down 1.2%
NYSE:OHI traded down $0.49 during trading hours on Wednesday, hitting $41.57. The stock had a trading volume of 1,767,922 shares, compared to its average volume of 1,629,333. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $44.42. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. The company has a market cap of $12.26 billion, a price-to-earnings ratio of 25.66, a P/E/G ratio of 2.20 and a beta of 0.71. The business's 50 day moving average is $40.60 and its 200-day moving average is $38.34.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. During the same quarter in the prior year, the firm earned $0.71 earnings per share. The firm's revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.4%. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.
Insider Activity
In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares of the company's stock, valued at $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
OHI has been the topic of several analyst reports. Wells Fargo & Company increased their price objective on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Mizuho increased their price objective on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a report on Thursday, September 11th. Scotiabank increased their price objective on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a report on Thursday, August 28th. Royal Bank Of Canada increased their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a report on Thursday, August 7th. Finally, Truist Financial increased their price objective on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Five research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $43.75.
View Our Latest Analysis on Omega Healthcare Investors
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Recommended Stories

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.